Dr W.M. Blankesteijn

Pinckaers, N. E. T., Blankesteijn, W. M., Peeters, R., Dijkstra, P., Tinnemans, R., Opperhuizen, A., van Schooten, F. J., & Vrolijk, M. (2026). Phenethylamines in pre-workout supplements alter arterial pressure, heart rate, and body temperature in rats. European Journal of Pharmacology, 1026, Article 178966. https://doi.org/10.1016/j.ejphar.2026.178966

Pinckaers, N. E. T., Sawicka, P. D., Wopken, J. P., Blankesteijn, W. M., van Schooten, F.-J., Opperhuizen, A., Vrolijk, M., & Westerink, R. H. S. (2026). In vitro inhibition of monoamine transport by amphetamine-like pre-workout supplement ingredients. Toxicology, 523, Article 154442. https://doi.org/10.1016/j.tox.2026.154442

Pinckaers, N. E. T., Blankesteijn, W. M., Leenders, P., Weltjens, E., Opperhuizen, A., Van Schooten, F.-J., & Vrolijk, M. (2026). Potential Cardiovascular Risks of Phenethylamine Analogues in Food Supplements: Evidence from Vasocontraction of Rat Artery Segments. Cardiovascular Toxicology, 26(4), Article 36. https://doi.org/10.1007/s12012-026-10109-8

Pinckaers, N. E. T., Blankesteijn, W. M., Mircheva, A., Punt, A., Opperhuizen, A., van Schooten, F.-J., & Vrolijk, M. (2025). Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry. Archives of Toxicology, 99(5), 1999-2021. https://doi.org/10.1007/s00204-025-03992-7

Baker, M. B., Hazell, G., van Rijt, S., Blankesteijn, W. M., Welting, T., den Akker, G. V., & Bauer, J. (2025). Teaching Chemistry in the New Bachelor “Regenerative Medicine and Technology”. Croatica Chemica Acta, 98(2), 157-166. https://doi.org/10.5562/cca4185

Manukjan, N., Fulton, D., Ahmed, Z., Blankesteijn, W. M., & Foulquier, S. (2025). Vascular endothelial growth factor: a double-edged sword in the development of white matter lesions. Neural Regeneration Research, 20(1), 191-192. https://doi.org/10.4103/NRR.NRR-D-23-01843

Manukjan, N., Chau, S., Caiment, F., van Herwijnen, M., Smeets, H. J., Fulton, D., Ahmed, Z., Blankesteijn, W. M., & Foulquier, S. (2024). Wnt7a Decreases Brain Endothelial Barrier Function Via β-Catenin Activation. Molecular Neurobiology, 61(7), 4854-4867. https://doi.org/10.1007/s12035-023-03872-0

Pinckaers, N. E. T., Blankesteijn, W. M., Mircheva, A., Shi, X., Opperhuizen, A., van Schooten, F.-J., & Vrolijk, M. F. (2024). In Vitro Activation of Human Adrenergic Receptors and Trace Amine-Associated Receptor 1 by Phenethylamine Analogues Present in Food Supplements. Nutrients, 16(11), Article 1567. https://doi.org/10.3390/nu16111567

Manukjan, N., Majcher, D., Leenders, P., Caiment, F., van Herwijnen, M., Smeets, H. J. J., Suidgeest, E., van der Weerd, L., Vanmierlo, T., Jansen, J. F. A., Backes, W. H. H., van Oostenbrugge, R. J. J., Staals, J., Fulton, D., Ahmed, Z., Blankesteijn, W. M., & Foulquier, S. (2023). Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood-brain barrier impairment. Acta neuropathologica communications, 11(1), Article 128. https://doi.org/10.1186/s40478-023-01627-5

Pinckaers, N., Blankesteijn, M., Opperhuizen, A., Van Schooten, F. J., & Vrolijk, M. (2022). In vitro pharmacological characterization of phenethylamine and alkylamine analogues found in nutritional supplements at human adrenergic and trace amine-associated receptors. Toxicology Letters, 368, S280-S280. https://doi.org/10.1016/j.toxlet.2022.07.739